טוען...
Thioredoxin decreases anthracycline cardiotoxicity, but sensitizes cancer cell apoptosis
Cardiotoxicity is a major limitation for anthracycline chemotherapy although anthracyclines are potent antitumor agents. The precise mechanism underlying clinical heart failure due to anthracycline treatment is not fully understood, but is believed to be due, in part, to lipid peroxidation and the g...
שמור ב:
| הוצא לאור ב: | Cardiovasc Toxicol |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7854973/ https://ncbi.nlm.nih.gov/pubmed/32880787 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12012-020-09605-2 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|